Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.

Ken Sawada1, Alasdair M Barr, Masato Nakamura

  • 1Department of Neuropsychiatry, Kochi Medical School, Kochi, Japan.

Archives of General Psychiatry
|March 9, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postnatal conversion of methylcytosine to hydroxymethylcytosine reconfigures the human neuronal epigenome.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal brain atrophy and mortality among people living in homelessness and precarious housing: A brief report of a longitudinal study.

PloS one·2026
Same author

Human brain prefrontal cortex proteomics identifies compromised energy metabolism and neuronal function in Schizophrenia.

Nature communications·2026
Same author

Dopamine Responses in Medial Frontal Cortex Are More Consistent with a Generalized Arousal Signal Than Signed Reward Prediction Errors.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Impairments in the sense of self in children with autism spectrum disorder.

Psychiatry research·2025
Same author

Reminiscent of the pre-diatom? A hitherto undescribed scaly bolidophyte Lepidoparma frigida gen. et sp. nov. in a new order Lepidoparmales based on morphology, phylogeny, and ecology.

Journal of phycology·2025

Schizophrenia is linked to lower levels of complexin II-complexin I proteins in the hippocampus, impacting cognitive function. These synaptic protein changes may contribute to cognitive deficits in schizophrenia patients.

Area of Science:

  • Neuroscience
  • Molecular Psychiatry
  • Synaptic Biology

Background:

  • Converging evidence suggests synaptic terminal abnormalities in schizophrenia.
  • Presynaptic protein machinery, including complexins I and II, is implicated in schizophrenia pathophysiology.

Purpose of the Study:

  • Quantify and localize complexin I and II in the hippocampus of schizophrenia patients.
  • Correlate complexin levels with excitatory and inhibitory terminal markers.
  • Investigate functional implications of complexin alterations.

Main Methods:

  • Immunocytochemistry used to analyze complexin I, complexin II, and vesicular transporters (GABA, glutamate) in human hippocampal sections.
  • Cognitive function assessed via medical record review and correlated with protein findings.

Related Experiment Videos

  • Rodent models exposed to drugs (haloperidol, amphetamine, ketamine) and memory tasks explored functional relevance.

    • Main Results:

    • Reduced complexin II-complexin I ratio observed in the hippocampus of individuals with schizophrenia compared to controls.
    • Complexin protein disturbances were more pronounced than those of vesicular GABA or glutamate transporters.
    • Lowered complexin II-complexin I ratio inversely correlated with cognitive impairment severity in schizophrenia patients.
    • Conversely, hippocampal complexin II-complexin I ratio increased in rats trained in memory tasks.

    Conclusions:

    • Hippocampal complexin protein pathology is a significant factor in schizophrenia.
    • Alterations in complexin proteins are particularly relevant to cognitive disturbances observed in schizophrenia.